Clinicians have tools to identify potentially inappropriate medications (PIMs) in older adults—but what about adults under 65? A new protocol led by our researchers outlines an international modified Delphi study to build expert consensus on PIMs for adults aged 18–65 years. 🔗 tinyurl.com/kpyyverh

Please join myself and @brianmackenna.bsky.social for a lunchtime webinar this Thursday, 11th June. We'll be talking about the current state of medicines data in Ireland and the potential it could deliver in the future. Registration details 👇

Brian@brianmackenna.bsky.social · 5mo ago

Would you like to learn a little about how the Irish healthcare service uses painkillers? Me & the great @frankmoriarty.bsky.social Frank will be giving a run down of the magnificent CDRx project which shed new light on prescribing in the HSE. shorturl.at/O01B4 #SpeirGorm #pharmsky #medsky

Ireland has amongst the highest over-the-counter codeine sales internationally. Meanwhile opioid prescribing in Ireland has risen, whilst falling in England. I wrote about why the Irish health service needs to confront its opioid problem on Linkedin: www.linkedin.com/pulse/irish-... brief🧵

The Irish health service needs to confront its opioid problem

Recent research shows Ireland has amongst the highest over-the-counter codeine sales internationally, and that prescriptions for painkillers, particularly opioids, have risen steadily over the last de...

linkedin.com

#DIAMOND's Anais Essilini presenting findings from an overview of reviews on medications associated with serotonin syndrome. Her work underscores the challenges of evidence synthesis for rare serious adverse events where reports are dominated by case reports #ICOD2026 #DIAMOND #deprescribing

DePhaRM's Zakir Khan presenting his work on adverse drug withdrawal events reported in US & EU pharmacovigilance databases #DIAMOND #deprescribing #ICOD2026

DePhaRM's Alex McKibben presents findings from her systematic review of international guidelines to identify patients for medication review in primary care. #ICOD2026 #DIAMOND #deprescribing

#DIAMOND's Ryan Muddiman presenting again today with findings from a cohort study examining medication interval patterns amongst older adults in primary care #deprescribing #ICOD2026

The morning kicking off with a plenary talk from Muhammad Mamdani on Applied AI in healthcare and the implications for #deprescribing, with #DIAMOND PI @frankmoriarty.bsky.social delivering the speaker introduction

Another RCSI colleague, Caroline McCarthy, now moderating a Fireside Chat with Ross Upshur on "Becoming what you research" at #ICOD2026. #DIAMOND #deprescribing

RCSI colleague and member of @frankmoriarty.bsky.social's DePhaRM group, Zakir Khan joins Ariel Green, Shin Liau, and Orla Sheehan for a panel discussion, moderated by @reeve-research.bsky.social on understanding adverse drug withdrawal events in #deprescribing. #ICOD2026 #DIAMOND

DIAMOND's @annsinead.bsky.social joins James Sheppard and John Tazare on a panel moderated by DIAMOND's @frankmoriarty.bsky.social to explore methodological challenges in studying deprescribing with real-world data. Lots of interest in this discussion. #ICOD2026 #DIAMOND #deprescribing

​DIAMOND collaborator Wade Thompson also on the #ICOD2026 program with a pre-conference workshop on "From preferences to practice: applying preference research to advance deprescribing" with Ariel Green & Aisling McEvoy. #ICOD2026 #DIAMOND #deprescribing

@dremilymcd.bsky.social kicking off proceedings with the #ICOD2026 welcoming address. #ICOD2026 #DIAMOND #deprescribing

Shout out to our RCSI colleague, Caroline McCarthy, who is taking part in a pre-conference panel on "How we prepare clinicians to deprescribe? An international perspective" #ICOD2026 #DIAMOND #deprescribing

The #ICOD2026 networking continues with the early career researcher networking session being led by DIAMOND's @frankmoriarty.bsky.social #DIAMOND #deprescribing

The #ICOD2026 pre-conference networking continues with the @deprescribeus.bsky.social Early Career Investigator meeting. Lovely to see UCC's Kieran Dalton as a panelist on the moderated panel on navigating your early-career path. Also feat Michelle Keller, Jinjiao Wang, moderated by Amanda Mixon

DIAMOND's @annsinead.bsky.social & @frankmoriarty.bsky.social kick off the morning by catching up with colleagues from @deprescribeus.bsky.social at the #ICOD2026 USDeN Junior Investigator breakfast. #DIAMOND #deprescribing

Associations between pharmaceutical industry interactions with physicians and chronic nonmalignant pain management prescribing practices: a systematic review link.springer.com/article/10.1... Mohammed Gharbia, Lydia Iladiva, @frankmoriarty.bsky.social, Tom Fahey & @jameslarkin13.bsky.social

Associations between pharmaceutical industry interactions with physicians and chronic nonmalignant pain management prescribing practices: a systematic review - Cost Effectiveness and Resource Allocati...

Cost Effectiveness and Resource Allocation - Chronic nonmalignant pain (CNMP) is commonly treated with opioids and other analgesics, yet prescribing carries risks and substantial costs. Promotional...

link.springer.com

Our first paper from the @diamond-derx.bsky.social research programme funded by @wellcometrust.bsky.social is out! We sought to understand how simulation studies in pharmacoepidemiology have been conducted, led by Dr Ryan Muddiman @rcsi.bsky.social

DIAMOND Research Programme@diamond-derx.bsky.social · 10mo ago

We are pleased to share our latest publication in Pharmacoepidemiology and Drug Safety (PDS). 🔗https://doi.org/10.1002/pds.70329​ We reviewed statistical simulations published in PDS, the flagship #pharmacoepidemiology journal, between 2017 and 2024 and focused on implementation & reporting. 1/4

We are pleased to share our latest publication in Pharmacoepidemiology and Drug Safety (PDS). 🔗https://doi.org/10.1002/pds.70329​ We reviewed statistical simulations published in PDS, the flagship #pharmacoepidemiology journal, between 2017 and 2024 and focused on implementation & reporting. 1/4

Just ten days left to apply for this Research Fellow position, focused on pharmacoepidemiology and deprescribing. More information about the DIAMOND programme available at: diamond-deprescribing.eu Full job description here (deadline July 7th): my.corehr.com/pls/rcsirecr...

Frank Moriarty@frankmoriarty.bsky.social · last yr.

Interested in medications, data and deprescribing? We're looking for a Research Fellow to join the @diamond-derx.bsky.social team @rcsi.bsky.social! If you're an experienced researcher interested in harnessing routine healthcare data, please apply by 7 July: my.corehr.com/pls/rcsirecr...

A conference exploring how clinical research, medication safety and patient empowerment could impact national initiatives to support ageing adults took place in Dublin today, organised by @rcsipophealth.bsky.social and @tcddublin.bsky.social

#DePhaRM group and @frankmoriarty.bsky.social were delighted to welcome Dr Justin Turner (@optimisingrxuse.bsky.social) for today’s @rcsi.bsky.social PBS seminar. He gave an inspiring look at Pharmacist-led #deprescribing in real-world care through the SaferMedsNL initiative. #ImplementationScience

Interested in medications, data and deprescribing? We're looking for a Research Fellow to join the @diamond-derx.bsky.social team @rcsi.bsky.social! If you're an experienced researcher interested in harnessing routine healthcare data, please apply by 7 July: my.corehr.com/pls/rcsirecr...

This early access original research study identifies five clinically relevant prescribing cascades in a national sample of more than half a million older adults in Ireland. #FMsky#Medsky #PrimaryCare www.annfammed.org/content/earl...

On Saturday, the Irish Times published a piece I wrote asking whether Novo Nordisk should be funding children’s playgrounds. We need to ask if there are hidden costs to Novo Nordisk funding parts of our education and health systems, costs that may not be worth paying for. shorturl.at/erwpH

Should the maker of Ozempic be funding children’s playgrounds in Ireland?

In 2023, Novo Nordisk was suspended by its own industry body in the UK for two years over its sponsorship of weight management courses for health professionals

shorturl.at

Well done to WP lead Ryan Muddiman & review co-authors: Florencia Ines Aiello Battan, John Tazare, @annaschultze.bsky.social, Teresa Perez, Li Wei, @fionaboland.bsky.social, @marywalsh14.bsky.social @frankmoriarty.bsky.social #CausalInference #Deprescribing #DIAMOND diamond-deprescribing.eu

DIAMOND WP2 is exploring how simulation can support target trial emulation in deprescribing research. We recently conducted a review of simulation studies - 📢preprint now here: doi.org/10.1101/2025.... We also attended a brilliant simulation course led by Tim Morris, UCL: tinyurl.com/UCLSimTraining

Pharmacoepidemiology simulation study practices: A methodological review

Purpose Simulation studies are used in pharmacoepidemiology for evaluating inferential methods in a controlled setting, whereby a known data-generating mechanism allows evaluation of the performance o...

doi.org

Last few days to apply for this funded PhD on deprescribing in chronic kidney disease, closes on Monday 2nd June!

Frank Moriarty@frankmoriarty.bsky.social · last yr.

We're looking for a PhD scholar for a @hrbireland.bsky.social funded 4-year project focused on prescribing and deprescribing in chronic kidney disease, based at @rcsi.bsky.social. If interested in pharmacoepi/health services research, please apply (D/L 2nd June): www.rcsi.com/dublin/resea...

Publication: We modelled the impact of post-2016 changes to prescription medicine co-payment charges and cost caps on out-of-pocket prescription expenditure Mean annual expenditure for medical card holders reduced from €117 to €55. For the DPS-group, it reduced from €719 to €555 shorturl.at/l7OAh

Modelling the impact of changes to prescription medicine cost-sharing schemes among middle aged and older adults

To assess impacts of government changes to prescription medicine co-payments on individuals’ out-of-pocket expenditure.Participants were community-dwe…

sciencedirect.com